Rachel A. Toroni

532 citations
9 papers · 425 indexed · h-index 7

Rachel A. Toroni

9 papers receiving 420 citations

Peers

Rachel A. Toroni
Comparison fields: 5 of 51
  • Molecular Biology 362
  • Oncology 129
  • Cell Biology 67
  • Cancer Research 50
  • Immunology and Allergy 17
Replace Hong-Jen Lee with:
Hong-Jen Lee Taiwan
Tomoatsu Hayashi Japan
Jasminka Omerović United Kingdom
Melanie Donahue United States
Luca Tordella United Kingdom
Sigrı́dur Valgeirsdóttir Sweden
Dennis Hsu United States
Xianting Huang China
Jelena Urosevic United Kingdom
Yuliya Petrova United States
Rachel A. Toroni relative to Hong-Jen Lee Taiwan Hong-Jen Lee's profile →
Citations per field
00.5×1.5×
Hong-Jen Lee · 1×
Citations per year

Countries citing papers authored by Rachel A. Toroni

Since Specialization
Citations

This map shows the geographic impact of Rachel A. Toroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. Toroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. Toroni more than expected).

Fields of papers citing papers by Rachel A. Toroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. Toroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. Toroni. The network helps show where Rachel A. Toroni may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rachel A. Toroni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rachel A. Toroni Line = papers co-authored together Rachel A. Toroni links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer
20142
2 201410
3 2014129
4 201328
5 201269
6 201226
7 2012122
8 201038
9 20101

About Rachel A. Toroni

Rachel A. Toroni is a scholar working on Immunology and Allergy, Molecular Biology and Cell Biology, having authored 9 papers that have together received 425 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Melanoma and MAPK Pathways (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Molecular Biology (362 citations), Oncology (129 citations) and Cell Biology (67 citations). Rachel A. Toroni has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Randall T. Moon, Andy J. Chien, Rima M. Kulikauskas, Olivia M. Lucero, Sunil Badve, Travis L. Biechele, Yesim Gökmen‐Polar, Richard G. James, Jamie N. Anastas and David W. Dawson. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026